• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Hofseth BioCare

Less than 1K followers

HBC

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus

Hofseth BioCare is a Norwegian company active in biotechnology. The company develops various protein and calcium powders, as well as salmon oil. By using patented technology, the company can extract substances for production at an early stage. The products are delivered in the form of dietary supplements and sold through health stores. The company was founded in 2009 and has its headquarters in Ålesund.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
30.6.
2026

General meeting '26

30.6.
2026

Interim report Q1'26

21.8.
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Regulatory press releaseyesterday

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026

Hofseth BioCare
Regulatory press release5/28/2026, 5:01 PM

HBC: Financial calendar

Hofseth BioCare
Regulatory press release5/21/2026, 11:22 PM

Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M

Hofseth BioCare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release5/6/2026, 6:45 PM

HBC: Financial calendar

Hofseth BioCare
Regulatory press release4/14/2026, 9:03 AM

Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas

Hofseth BioCare
Regulatory press release4/14/2026, 9:03 AM

Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas

Hofseth BioCare
Regulatory press release3/27/2026, 4:08 PM

Hofseth BioCare ASA: HBC ANNUAL REPORT 2025

Hofseth BioCare
Regulatory press release2/13/2026, 7:15 AM

Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT

Hofseth BioCare
Regulatory press release2/11/2026, 4:05 PM

HBC: Notification of major shareholdings

Hofseth BioCare
Regulatory press release2/11/2026, 4:05 PM

Notification of major shareholdings

Hofseth BioCare
Regulatory press release12/15/2025, 9:04 AM

Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement

Hofseth BioCare
Regulatory press release12/3/2025, 12:44 PM

HBC: Financial calendar

Hofseth BioCare
Regulatory press release11/21/2025, 9:28 AM

Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth BioCare
Regulatory press release11/21/2025, 9:14 AM

Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING

Hofseth BioCare
Regulatory press release11/20/2025, 10:30 AM

Hofseth BioCare ASA: Extraordinary General Meeting completed

Hofseth BioCare
Regulatory press release11/20/2025, 8:11 AM

Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING

Hofseth BioCare
Regulatory press release11/20/2025, 7:58 AM

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

Hofseth BioCare
Regulatory press release11/20/2025, 7:58 AM

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

Hofseth BioCare
Regulatory press release11/10/2025, 7:33 AM

Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering

Hofseth BioCare
Regulatory press release11/7/2025, 7:55 AM

Hofseth BioCare ASA: Terms of the Subsequent Offering

Hofseth BioCare